Trial Site Detail
Drug: |
Nivolumab + BMS-986016 |
|||
|---|---|---|---|---|
Trial: |
Safety Study of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Active, not recruiting |
|||
Dana Farber Cancer Institute450 Brookline Ave |
Principal Investigator: |
|
|---|---|
Contact: |
F. Stephen Hodi, Site 0001 617-582-7603 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Dana Farber Cancer Institute Website: |
http://www.dana-farber.org/Research/Clinical-Trials.aspx |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.